Tilray Brands currently generates a higher total revenue base than Canopy Growth, maintaining a consistently larger top-line financial footprint across its various reported operating segments and international geographic regions during this specific tracking period.
While both companies experienced standard quarter-over-quarter revenue fluctuations over the roughly eight-quarter reporting period, Tilray Brands continuously maintained higher overall revenue levels than its counterpart during every single calendar quarter shown in the standardized data table.
Investors evaluating these publicly traded businesses should closely monitor the financial data to watch whether the established revenue gap between the two companies continues to widen over time or if Canopy Growth begins to narrow the difference in upcoming quarters.
Canopy Growth (NASDAQ:CGC) primarily generates revenue by selling medical and recreational cannabis products to consumers across several international regions.
It recently secured renewed European Union manufacturing certifications for multiple Canadian facilities to support its supply chain, and it expanded its international medical cannabis operations by launching new product formats in Australia, supplying four Canadian-grown flower strains to the United Kingdom, and appointing a dedicated country manager for its growing business in Germany.
Tilray Brands (NASDAQ:TLRY) earns most of its revenue by selling cannabis, alcoholic beverages, and various wellness products globally.
It recently expanded its total annual cannabis production capacity to approximately 275 metric tonnes across its cultivation facilities in Canada and Portugal, and its beverage division secured new regional distribution agreements for its craft spirits while finalizing multiple professional sports partnerships for its brands across the United States and the United Kingdom.
Revenue here refers to the data provider's standardized income-statement revenue line item, and it provides a baseline measurement of customer demand before business expenses are deducted.
Canopy Growth vs. Tilray Brands Revenue over the last 8 quarters. Figures: Canopy Growth shown in U.S. dollars, converted from Canadian dollars.
| Calendar quarter | Canopy Growth Revenue | Tilray Brands Revenue |
|---|---|---|
| Q4 2024 | $53.5 million (quarter ended Dec. 31, 2024) | $210.9 million (quarter ended Nov. 30, 2024) |
| Q1 2025 | $45.3 million (quarter ended March 31, 2025) | $185.8 million (quarter ended Feb. 28, 2025) |
| Q2 2025 | $52.1 million (quarter ended June 30, 2025) | $224.5 million (quarter ended May 31, 2025) |
| Q3 2025 | $48.4 million (quarter ended Sept. 30, 2025) | $209.5 million (quarter ended Aug. 31, 2025) |
| Q4 2025 | $73.3 million (quarter ended Dec. 31, 2025) | $217.5 million (quarter ended Nov. 30, 2025) |
| Q1 2026 | $51.9 million (quarter ended March 31, 2026) | $206.7 million (quarter ended Feb. 28, 2026) |
| Q2 2026 | $58.6 million (quarter ended June 30, 2026) | $281.7 million (quarter ended May 31, 2026) |
| Q3 2026 | Not yet reported | $257.1 million (quarter ended Aug. 31, 2026) |
Normally, the first thing to note when examining a company's revenue trend is seasonality: some times of the year have stronger buying patterns than others. For most stocks, compare revenue year over year, by quarter. Even as a relatively new business sector, there is seasonality in cannabis, with sales seeing periodic strength during the summer months and especially April 20, given the calendar date is a well-known marijuana pop culture reference.
When viewing the chart for both Tilray and Canopy Growth from left to right, it may seem revenue is volatile, but in fact, viewed quarterly against the prior year's comparable quarter, there is steady growth for both.
Revenue is probably the simplest metric investors have to judge a business by. It is also one of the most important ones. As the chart shows, look for rising revenue over similar periods of each year, and take comparable-quarter stagnation, or worse, declines, as a red flag.
Data source: Financial Modeling Prep. Canopy Growth's figures are converted from Canadian dollars to U.S. dollars. Data as of Oct. 22, 2026.
Before you buy stock in Canopy Growth, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Canopy Growth wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $334,631!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,312,844!*
Now, it’s worth noting Stock Advisor’s total average return is 893% — a market-crushing outperformance compared to 213% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of October 30, 2026.
Brendan Coffey has no position in any of the stocks mentioned. The Motley Fool recommends Tilray Brands. The Motley Fool has a disclosure policy.